Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome
Open Access
- 1 August 2004
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (8) , 4410-4415
- https://doi.org/10.1128/iai.72.8.4410-4415.2004
Abstract
Severe acute respiratory syndrome (SARS) is an acute infectious disease of the respiratory system. Although a novel coronavirus has been identified as the causative agent of SARS, the pathogenic mechanisms of SARS are not understood. In this study, sera were collected from healthy donors, patients with SARS, patients with severe SARS, and patients with SARS in convalescence. The serum concentrations of interleukin-1 (IL-1), IL-4, IL-6, IL-8, IL-10, tumor growth factor beta (TGF-β), tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ) were measured by enzyme-linked immunosorbent assays (ELISA). The concentrations of IL-1 and TNF-α were not significantly different in different groups. The IL-6 concentration was increased in SARS patients and was significantly elevated in severe SARS patients, but the IL-6 concentrations were similar in convalescent patients and control subjects, suggesting that there was a positive relationship between the serum IL-6 concentration and SARS severity. The concentrations of IL-8 and TGF-β were decreased in SARS patients and significantly reduced in severe SARS patients, but they were comparable in convalescent SARS patients and control subjects, suggesting that there was a negative relationship between the IL-8 and TGF-β concentrations and SARS severity. The concentrations of IFN-γ, IL-4, and IL-10 showed significant changes only in convalescent SARS patients. The IFN-γ and IL-4 levels were decreased, while the levels of IL-10 were increased, and the differences between convalescent SARS patients and other patient groups were statistically significant. These results suggest that there are different immunoregulatory events during and after SARS and may contribute to our understanding of the pathogenesis of this syndrome.Keywords
This publication has 24 references indexed in Scilit:
- Safety, Pharmacokinetics, and Pharmacodynamics of Drotrecogin Alfa (Activated) in Children With Severe SepsisPediatrics, 2004
- Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsisThe FASEB Journal, 2003
- Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndromeThe Journal of Pathology, 2003
- Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysisBMJ, 2003
- A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Transforming growth factor-β: A mediator of cell regulation in acute respiratory distress syndromeCritical Care Medicine, 2003
- Tumor Necrosis Factor-α and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathologyEuropean Journal of Immunology, 2001
- Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedemaEuropean Respiratory Journal, 1996